Iofina (IOF) Competitors

GBX 49.48 +2.48 (+5.28%)

As of 05/14/2026 12:34 PM Eastern

IOF vs. ESNT, ZTF, TET, SYNT, and HDD

Should you buy Iofina stock or one of its competitors? MarketBeat compares Iofina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Iofina include Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Synthomer (SYNT), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry.

How does Iofina compare to Essentra?

Essentra (LON:ESNT) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Essentra currently has a consensus target price of GBX 150, suggesting a potential upside of 82.93%. Iofina has a consensus target price of GBX 60, suggesting a potential upside of 21.26%. Given Essentra's higher possible upside, research analysts clearly believe Essentra is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Iofina has a net margin of 11.84% compared to Essentra's net margin of 0.70%. Iofina's return on equity of 14.89% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Essentra	0.70%	0.79%	1.74%
Iofina	11.84%	14.89%	5.18%

69.5% of Essentra shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 0.5% of Essentra shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Iofina has lower revenue, but higher earnings than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essentra	£302M	0.77	£3.50M	£0.70	117.14
Iofina	£66.52M	1.43	£4.28M	£4.00	12.37

In the previous week, Essentra had 1 more articles in the media than Iofina. MarketBeat recorded 2 mentions for Essentra and 1 mentions for Iofina. Iofina's average media sentiment score of 0.75 beat Essentra's score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Essentra	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Iofina	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Essentra has a beta of 0.895, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Iofina has a beta of 1.1947325, meaning that its stock price is 19% more volatile than the broader market.

Summary

Iofina beats Essentra on 10 of the 16 factors compared between the two stocks.

How does Iofina compare to Zotefoams?

Zotefoams (LON:ZTF) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Zotefoams currently has a consensus target price of GBX 605, suggesting a potential upside of 55.93%. Iofina has a consensus target price of GBX 60, suggesting a potential upside of 21.26%. Given Zotefoams' higher possible upside, research analysts clearly believe Zotefoams is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Iofina	11.84%	14.89%	5.18%

29.5% of Zotefoams shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.20	£9.80M	£44.87	8.65
Iofina	£66.52M	1.43	£4.28M	£4.00	12.37

In the previous week, Zotefoams and Zotefoams both had 1 articles in the media. Iofina's average media sentiment score of 0.75 beat Zotefoams' score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zotefoams	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Iofina	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zotefoams has a beta of 1.255, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Iofina has a beta of 1.1947325, meaning that its stock price is 19% more volatile than the broader market.

Summary

Zotefoams beats Iofina on 10 of the 14 factors compared between the two stocks.

How does Iofina compare to Treatt?

Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

Treatt currently has a consensus target price of GBX 248.33, suggesting a potential downside of 16.95%. Iofina has a consensus target price of GBX 60, suggesting a potential upside of 21.26%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treatt	3.40%	3.22%	6.72%
Iofina	11.84%	14.89%	5.18%

17.4% of Treatt shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 4.1% of Treatt shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treatt	£128.29M	1.38	£11.22M	£7.22	41.41
Iofina	£66.52M	1.43	£4.28M	£4.00	12.37

In the previous week, Treatt and Treatt both had 1 articles in the media. Iofina's average media sentiment score of 0.75 beat Treatt's score of 0.67 indicating that Iofina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treatt	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Iofina	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treatt has a beta of 0.677, meaning that its share price is 32% less volatile than the broader market. Comparatively, Iofina has a beta of 1.1947325, meaning that its share price is 19% more volatile than the broader market.

Summary

Iofina beats Treatt on 8 of the 14 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Synthomer (LON:SYNT) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A
Iofina	£66.52M	1.43	£4.28M	£4.00	12.37

In the previous week, Synthomer and Synthomer both had 1 articles in the media. Iofina's average media sentiment score of 0.75 beat Synthomer's score of 0.47 indicating that Iofina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synthomer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Iofina	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

19.9% of Synthomer shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 5.0% of Synthomer shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Iofina	11.84%	14.89%	5.18%

Synthomer currently has a consensus price target of GBX 86.75, suggesting a potential downside of 17.69%. Iofina has a consensus price target of GBX 60, suggesting a potential upside of 21.26%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Synthomer has a beta of 0.922, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Iofina has a beta of 1.1947325, indicating that its stock price is 19% more volatile than the broader market.

Summary

Iofina beats Synthomer on 13 of the 15 factors compared between the two stocks.

How does Iofina compare to Hardide?

Hardide (LON:HDD) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

Hardide has a beta of 0.972, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Iofina has a beta of 1.1947325, indicating that its stock price is 19% more volatile than the broader market.

10.2% of Hardide shares are owned by institutional investors. Comparatively, 2.5% of Iofina shares are owned by institutional investors. 65.7% of Hardide shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Iofina has a net margin of 11.84% compared to Hardide's net margin of 3.49%. Iofina's return on equity of 14.89% beat Hardide's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hardide	3.49%	5.59%	-9.80%
Iofina	11.84%	14.89%	5.18%

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hardide	£6.03M	4.94	-£1.89M	£0.20	189.00
Iofina	£66.52M	1.43	£4.28M	£4.00	12.37

Iofina has a consensus price target of GBX 60, suggesting a potential upside of 21.26%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Hardide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hardide	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Iofina had 1 more articles in the media than Hardide. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Hardide. Iofina's average media sentiment score of 0.75 beat Hardide's score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Overall Sentiment
Hardide	Neutral
Iofina	Positive

Summary

Iofina beats Hardide on 12 of the 16 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IOF vs. The Competition

Export

Metric	Iofina	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£94.93M	£8.83B	£5.03B	£2.79B
Dividend Yield	2.88%	3.47%	4.97%	6.09%
P/E Ratio	12.37	17.51	23.56	366.15
Price / Sales	1.43	110.94	7,249.55	88,429.84
Price / Cash	7.96	19.25	27.69	27.89
Price / Book	2.20	3.24	7.04	7.74
Net Income	£4.28M	£213.62M	£159.01M	£5.89B
7 Day Performance	5.50%	2.03%	1.00%	0.69%
1 Month Performance	59.61%	8.69%	2.65%	2.42%
1 Year Performance	119.91%	32.05%	86.31%	86.87%

Iofina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IOF Iofina	3.0375 of 5 stars	GBX 49.48 +5.3%	GBX 60 +21.3%	+112.8%	£94.93M	£66.52M	12.37	95	High Trading Volume
ESNT Essentra	3.6538 of 5 stars	GBX 81.70 +0.2%	GBX 150 +83.6%	-16.5%	£232.31M	£302M	116.71	350
ZTF Zotefoams	3.8866 of 5 stars	GBX 399.61 +0.9%	GBX 605 +51.4%	+43.7%	£195.50M	£158.49M	8.91	549	Gap Up
TET Treatt	0.9651 of 5 stars	GBX 299 flat	GBX 248.33 -16.9%	+16.3%	£176.52M	£128.29M	35.77	350
SYNT Synthomer	1.4463 of 5 stars	GBX 97 +40.8%	GBX 81.75 -15.7%	-7.7%	£158.57M	£1.74B	N/A	4,200	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IOF) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Iofina (IOF) Competitors